Orphan drugs

Results: 558



#Item
11Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2016-08-04 23:27:38
12TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

Add to Reading List

Source URL: www.nicedsu.org.uk

Language: English
13Intellectual Property Listings NAME FIRM LOCATION

Intellectual Property Listings NAME FIRM LOCATION

Add to Reading List

Source URL: www.managingip.com

Language: English - Date: 2015-09-23 06:22:13
14Microsoft Word - press release Neuroscience 2011 final1.doc

Microsoft Word - press release Neuroscience 2011 final1.doc

Add to Reading List

Source URL: www.neurotune.com

Language: English - Date: 2011-12-08 07:33:40
15TRIUMPH I study: Double Blind Placebo Controlled Clinical Investigation into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients with Severe Pulmonary Arterial Hypertension

TRIUMPH I study: Double Blind Placebo Controlled Clinical Investigation into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients with Severe Pulmonary Arterial Hypertension

Add to Reading List

Source URL: www.tyvaso.com

Language: English - Date: 2016-07-15 14:06:25
16Corporate Profile EUROPEAN PIONEER AOP Orphan researches, develops, produces and distributes innovative drugs and administration methods for rare diseases – and has become

Corporate Profile EUROPEAN PIONEER AOP Orphan researches, develops, produces and distributes innovative drugs and administration methods for rare diseases – and has become

Add to Reading List

Source URL: www.aoporphan.com

Language: English - Date: 2016-04-27 08:48:48
    17From bloodjournal.hematologylibrary.org at Dana-Farber Cancer Institute on August 23, 2011. For personal use only: Prepublished online June 8, 2011; doi:blood

    From bloodjournal.hematologylibrary.org at Dana-Farber Cancer Institute on August 23, 2011. For personal use only: Prepublished online June 8, 2011; doi:blood

    Add to Reading List

    Source URL: michorlab.dfci.harvard.edu

    Language: English - Date: 2011-08-23 09:56:20
    18Microsoft Wordfile00

    Microsoft Wordfile00

    Add to Reading List

    Source URL: michorlab.dfci.harvard.edu

    Language: English - Date: 2014-10-28 13:51:00
    19correspondence Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up Despite their efficacy in inducing deep and

    correspondence Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up Despite their efficacy in inducing deep and

    Add to Reading List

    Source URL: michorlab.dfci.harvard.edu

    Language: English - Date: 2013-12-12 17:40:33
    20Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia Kevin Leder1., Jasmine Foo2., Brian Skaggs3, Mercedes Gorre4, Charles L. Sawyers5, Franziska

    Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia Kevin Leder1., Jasmine Foo2., Brian Skaggs3, Mercedes Gorre4, Charles L. Sawyers5, Franziska

    Add to Reading List

    Source URL: michorlab.dfci.harvard.edu

    Language: English - Date: 2011-12-13 09:42:07